Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina

D. Costigan, P. Dal Cin, C. Fletcher, M. Nucci, C. Parra‐Herran, David B. Chapel
{"title":"Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina","authors":"D. Costigan, P. Dal Cin, C. Fletcher, M. Nucci, C. Parra‐Herran, David B. Chapel","doi":"10.1097/PAS.0000000000001906","DOIUrl":null,"url":null,"abstract":"Low-grade fibromyxoid sarcoma (LGFMS) is a malignancy with propensity for late relapse that principally affects deep soft tissues of the extremities and trunk. Its occurrence in the lower female genital tract is rare, and thus it may not be always considered in the differential diagnosis. We describe the salient features of 7 vulvovaginal LGFMS identified in the authors’ consultation files. Clinical information was obtained from referring pathologists. Archival slides were reviewed, and immunohistochemistry and fluorescence in situ hybridization were performed in cases with available material. Median age was 40 years (range, 34 to 58 y). Primary sites included vulva (n=6) and vagina (n=1). Tumors were 1.2 to 8.7 cm (median, 5.0 cm) in size and grossly circumscribed with firm to focally gelatinous cut surfaces. Microscopically, 5/7 had infiltrative edges. All tumors showed fibrous and myxoid areas, with lobulated myxoid foci in 5/7, comprising storiform, patternless, or (less often) fascicular arrangement of spindled to stellate cells with bland, slender to ovoid nuclei. In all cases, mitoses were <1/2.4 mm2, and necrosis was absent. Capillary “arcades” were seen in 3/7. Margins were positive in 3/6. Immunohistochemistry showed positive epithelial membrane antigen in 4/6 and MUC4 in 5/6. Fluorescence in situ hybridization detected FUS rearrangement in 5/7. Both tumors without FUS rearrangement were also negative for EWSR1 rearrangement. All 5 patients with available follow-up were alive and disease-free 10 to 150 months (median, 57 mo) after diagnosis. However, a review of vulvovaginal/pelvic LGFMS previously reported shows recurrences as late as 45 years after initial diagnosis. Pathologists need to be aware that LGFMS can arise in the vulvovaginal region. Tumor lobulation, capillary arcades, and positive MUC4 are helpful features distinguishing LGFMS from other bland myxoid spindle cell neoplasms in the lower female genital tract. Molecular testing can be useful in challenging cases. Complete excision is feasible for most vulvovaginal LGFMS. Long-term surveillance is required as local and/or distant spread can occur decades after diagnosis.","PeriodicalId":275221,"journal":{"name":"The American Journal of Surgical Pathology","volume":"33 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American Journal of Surgical Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/PAS.0000000000001906","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Low-grade fibromyxoid sarcoma (LGFMS) is a malignancy with propensity for late relapse that principally affects deep soft tissues of the extremities and trunk. Its occurrence in the lower female genital tract is rare, and thus it may not be always considered in the differential diagnosis. We describe the salient features of 7 vulvovaginal LGFMS identified in the authors’ consultation files. Clinical information was obtained from referring pathologists. Archival slides were reviewed, and immunohistochemistry and fluorescence in situ hybridization were performed in cases with available material. Median age was 40 years (range, 34 to 58 y). Primary sites included vulva (n=6) and vagina (n=1). Tumors were 1.2 to 8.7 cm (median, 5.0 cm) in size and grossly circumscribed with firm to focally gelatinous cut surfaces. Microscopically, 5/7 had infiltrative edges. All tumors showed fibrous and myxoid areas, with lobulated myxoid foci in 5/7, comprising storiform, patternless, or (less often) fascicular arrangement of spindled to stellate cells with bland, slender to ovoid nuclei. In all cases, mitoses were <1/2.4 mm2, and necrosis was absent. Capillary “arcades” were seen in 3/7. Margins were positive in 3/6. Immunohistochemistry showed positive epithelial membrane antigen in 4/6 and MUC4 in 5/6. Fluorescence in situ hybridization detected FUS rearrangement in 5/7. Both tumors without FUS rearrangement were also negative for EWSR1 rearrangement. All 5 patients with available follow-up were alive and disease-free 10 to 150 months (median, 57 mo) after diagnosis. However, a review of vulvovaginal/pelvic LGFMS previously reported shows recurrences as late as 45 years after initial diagnosis. Pathologists need to be aware that LGFMS can arise in the vulvovaginal region. Tumor lobulation, capillary arcades, and positive MUC4 are helpful features distinguishing LGFMS from other bland myxoid spindle cell neoplasms in the lower female genital tract. Molecular testing can be useful in challenging cases. Complete excision is feasible for most vulvovaginal LGFMS. Long-term surveillance is required as local and/or distant spread can occur decades after diagnosis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
外阴及阴道低度纤维黏液样肉瘤
低级别纤维黏液样肉瘤(LGFMS)是一种晚期复发倾向的恶性肿瘤,主要影响四肢和躯干的深层软组织。它发生在下女性生殖道是罕见的,因此它可能不总是考虑在鉴别诊断。我们描述了在作者的咨询文件中确定的7外阴阴道LGFMS的显著特征。临床资料来自转诊病理学家。回顾档案载玻片,在有可用材料的情况下进行免疫组织化学和荧光原位杂交。中位年龄为40岁(34 - 58岁)。原发部位包括外阴(n=6)和阴道(n=1)。肿瘤大小为1.2 - 8.7 cm(中位,5.0 cm),大体边界分明,切面坚硬,局部呈凝胶状。镜下5/7有浸润边缘。所有肿瘤均呈纤维状和黏液样区,5/7为分叶状黏液样灶,包括纺锤状至星状细胞的故事状、无模式或(较少)束状排列,细胞核温和、细长至卵形。所有病例均有丝分裂<1/2.4 mm2,无坏死。7月3日可见毛细血管“拱廊”。3/6的利润率为正。免疫组化示上皮膜抗原阳性4/6,MUC4阳性5/6。荧光原位杂交检测到5/7的FUS重排。无FUS重排的两例肿瘤也均为EWSR1重排阴性。所有5例可随访的患者在诊断后10至150个月(中位,57个月)存活且无病。然而,先前报道的外阴阴道/盆腔LGFMS的回顾显示,在初次诊断后45年复发。病理学家需要意识到LGFMS可能出现在外阴阴道区域。肿瘤分叶、毛细血管拱形和MUC4阳性是鉴别LGFMS与其他女性下生殖道粘液样梭形细胞肿瘤的重要特征。分子检测在具有挑战性的情况下是有用的。对于大多数外阴阴道LGFMS,完全切除是可行的。需要长期监测,因为局部和/或远处传播可能在诊断后数十年发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Superficial CD34-Positive Fibroblastic Tumor Localized Malignant Peritoneal Mesothelioma (LMPeM) in Women: A Clinicopathologic Study of 18 Cases Gastroesophageal Glomus Tumors “Malignant Mesenchymoma” Revisited Clinicopathologic and Immunohistochemical Characterization of Sarcomatoid Chromophobe Renal Cell Carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1